Recursion Pharmaceuticals, Inc. (RXRX)
4.25
-0.15
(-3.41%)
USD |
NASDAQ |
Dec 26, 16:00
4.20
-0.05
(-1.18%)
Pre-Market: 08:32
Recursion Pharmaceuticals EPS Diluted (Quarterly): -0.363 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 0.0634 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Amicus Therapeutics, Inc. | 0.0558 |
| iBio, Inc. | -0.108 |
| GT Biopharma, Inc. | -0.8268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -162.25M |
| Revenue (Quarterly) | 5.175M |
| Total Expenses (Quarterly) | 167.43M |
| Enterprise Value | 1.631B |
| Gross Profit Margin (Quarterly) | -442.7% |
| Profit Margin (Quarterly) | -3.14K% |
| Earnings Yield | -42.59% |
| Normalized Earnings Yield | -42.59 |